Divisions of Community and Family Medicine, University of Miyazaki, Miyazaki, Japan.
Am J Hypertens. 2011 Jul;24(7):783-8. doi: 10.1038/ajh.2011.46. Epub 2011 Mar 31.
Our aim was to examine the association between heart rate (HR) and visceral obesity and abnormal fat distribution in patients undergoing treatment for hypertension. We also ascertained whether such associations differ depending on the time of day when HR is measured and the venue at which the measurement is carried out (office or home).
The study enrolled a total of 390 patients (mean age 63.9 years; 45% men) receiving treatment with antihypertensive drugs other than β blockers or nondihydropyridine Ca-channel blockers. Office blood pressure (BP) and HR as well as home BP and HR, both morning and evening, were measured in all these patients for 14 days. The amount of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were determined using abdominal computed tomography (CT).
Evening HR was positively associated with VAT (r = 0.26) and negatively associated with SAT (r = -0.16); as a consequence, evening HR was closely associated with the VAT/SAT ratio (r = 0.30; all P < 0.01). In contrast, neither office nor morning HR was associated with VAT. The significant association between evening HR and VAT remained unchanged even after adjustment for significant covariates including SAT (P = 0.001). A multiple logistic regression analysis revealed that a 1-s.d. increase (10 beats per minute) in evening HR was significantly associated with visceral obesity (defined as VAT ≥100 cm)(2) (odds ratio (95% confidence interval: 1.7 (1.3-2.3)), P < 0.001), and that this association was independent of body mass index (BMI) and abdominal obesity (waist circumference ≥85 cm for men and ≥90 cm for women).
In these patients receiving treatment for hypertension, high evening HR was associated with visceral obesity, independent of the presence of subcutaneous fat and BMI. This novel finding could explain why cardiovascular risk is higher in individuals with high HR.
本研究旨在探讨心率(HR)与接受高血压治疗患者的内脏肥胖和异常脂肪分布之间的关系。我们还确定了这些关联是否因测量 HR 的时间和进行测量的地点(办公室或家中)而有所不同。
该研究共纳入 390 名接受除β受体阻滞剂和非二氢吡啶类钙通道阻滞剂以外的降压药物治疗的患者(平均年龄 63.9 岁,45%为男性)。所有患者均连续 14 天测量诊室血压(BP)和 HR,以及早晚家庭 BP 和 HR。使用腹部计算机断层扫描(CT)测量内脏脂肪组织(VAT)和皮下脂肪组织(SAT)的量。
晚上 HR 与 VAT 呈正相关(r = 0.26),与 SAT 呈负相关(r = -0.16);因此,晚上 HR 与 VAT/SAT 比值密切相关(r = 0.30;均 P < 0.01)。相比之下,诊室和早晨 HR 均与 VAT 无关。即使在校正包括 SAT 在内的多个重要混杂因素后,晚上 HR 与 VAT 之间的显著关联仍然存在(P = 0.001)。多因素逻辑回归分析显示,晚上 HR 每增加 1 个标准差(10 次/分钟)与内脏肥胖(定义为 VAT ≥100 cm)显著相关(比值比(95%置信区间):1.7(1.3-2.3),P < 0.001),并且这种关联独立于体重指数(BMI)和腹部肥胖(男性腰围≥85 cm,女性腰围≥90 cm)。
在接受高血压治疗的这些患者中,晚上 HR 较高与内脏肥胖相关,与皮下脂肪和 BMI 无关。这一新发现可以解释为什么 HR 较高的个体心血管风险更高。